Daratumumab for multiple myeloma

Croizier, C; Bailly, S

Croizier, C (reprint author), CHU Clermont Ferrand, Serv Therapie Cellulaire & Hematol Clin, 1 Rue Lucie Aubrac, F-63100 Clermont Ferrand, France.

BULLETIN DU CANCER, 2018; 105 (11): 985

Abstract

Daratumumab is a monoclonal antibody that targets CD38. It has on anti-tumor action on the myeloma cell and an immunomodulatory action. For relapsing ......

Full Text Link